The incidence of antidepressant discontinuation symptoms appears to be much lower than was previously thought, results from a new meta-analysis of studies assessing this issue showed. […]

LONG BEACH, California — A small fraction of patients with pulmonary embolism (PE) who are eligible for advanced therapies are actually getting them, reported investigators who […]

LONG BEACH, California — Percutaneous coronary intervention procedures performed using the radial artery in the arm have almost tripled in the past decade, according to a […]

STOCKHOLM, Sweden — New data on clazakizumab, a monoclonal antibody targeting interleukin-6 (IL-6), and home hemodialysis suggest the potential of two ways to reduce the high […]

FROM ASCO 2024 Asciminib, a first-in-class tyrosine kinase inhibitor (TKI), shows efficacy and significantly improved tolerability compared with standard of care TKIs as a frontline treatment […]

In a study of adults, an increase of 1 g in estimated 24-hour urinary sodium excretion was associated with an 11% higher odds of an atopic […]

Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead with […]

Despite overall declines in cancer incidence and mortality, population growth and aging are predicted to drive an increase in the absolute number of people receiving a […]